We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Fagron NV (FAGR) NPV

Sell:€17.90 Buy:€18.46 Change: €0.12 (0.66%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:€17.90
Buy:€18.46
Change: €0.12 (0.66%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:€17.90
Buy:€18.46
Change: €0.12 (0.66%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. The Company specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. It operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.

Contact details

Address:
Venecoweg 20A
NAZARETH
9810
Belgium
Telephone:
+32 (80) 012880
Website:
https://fagron.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
FAGR
ISIN:
BE0003874915
Market cap:
€1.34 billion
Shares in issue:
72.99 million
Sector:
Health Care Distributors
Exchange:
Euronext Brussels
Country:
Belgium
Currency:
Euro
Indices:
n/a

Key personnel

  • Rafael Padilla
    Chief Executive Officer, Executive Director
  • Karin de Jong
    Chief Financial Officer, Executive Director
  • Vera Bakker
    Chief Operating Officer
  • Geraldino Neder
    Area Leader, Latin America
  • Maarten Pouw
    Area Leader, EMEA
  • Andrew Pulido
    Area Leader, North America
  • Johan Verlinden
    Head - Legal and M&A

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.